Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma

NCT00226473 is registered in ClinicalTrials.gov with Dermatologic Cooperative Oncology Group as lead sponsor.

NCT NCT00226473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma
Lead sponsor
Dermatologic Cooperative Oncology Group
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2001
Completion date
September 30, 2005
Enrollment
200
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma